Table of Contents
ISRN Transplantation
Volume 2013 (2013), Article ID 281285, 5 pages
http://dx.doi.org/10.5402/2013/281285
Clinical Study

Tacrolimus Dose Modification in Hematopoietic Cell Transplant Recipients Following a Change in Therapy from Fluconazole to Voriconazole

1College of Pharmacy, The University of Tennessee, Knoxville Campus, 1924 Alcoa Highway, P.O. Box 117, Knoxville, TN 37920, USA
2Department of Clinical Pharmacy, School of Pharmacy and Section of Infectious Diseases, School of Medicine, West Virginia University, Morgantown, WV 26506, USA
3Department of Pharmacy and Mary Babb Randolph Cancer Center, West Virginia University Healthcare, Morgantown, WV 26506, USA

Received 13 August 2012; Accepted 30 August 2012

Academic Editors: R. De la Camara, H.-J. Kim, and R. Rezzani

Copyright © 2013 Anthony J. Guarascio et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Anthony J. Guarascio, Douglas Slain, and Aaron Cumpston, “Tacrolimus Dose Modification in Hematopoietic Cell Transplant Recipients Following a Change in Therapy from Fluconazole to Voriconazole,” ISRN Transplantation, vol. 2013, Article ID 281285, 5 pages, 2013. doi:10.5402/2013/281285